Skip to main content

Intellia Therapeutics, Inc.

NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652130

In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Intellia Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
3 insiders, $506.6K in total
Insiders trading
3
Net value
−$506.6K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Intellia Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Intellia Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Leonard John MPresident and CEO1,147,064Aug 24, 20264
Dulac Edward J IIIEVP, Chief Financial Officer148,175Jul 24, 20264
Dube Michael PVP, Chief Accounting Officer66,886Jul 6, 20264
Cohen Fred EDirector216,653Jun 10, 20262
Verwiel FrankDirector35,148Jun 10, 20261
Goff BrianDirector32,609Jun 10, 20261
Chase William JDirector143,893Jun 10, 20261
Goodman JesseDirector33,559Jun 10, 20261
Keresty GeorgiaDirector41,083Jun 10, 20261
Bhanji MunaDirector36,403Jun 10, 20261
Basta JamesEVP, General Counsel156,794Mar 3, 20262
Lebwohl DavidEVP, Chief Medical Officer131,192Mar 3, 20262
Clark ElianaEVP, Chief Technical Officer93,864Mar 3, 20262
Schultes Birgit CEVP, Chief Scientific Officer137,733Mar 3, 20263
Sepp-Lorenzino LauraEVP, Chief Scientific Officer77,388Jan 7, 20250
Hicks DerekEVP, Chief Business Officer59,878Jan 7, 20250
Goddard GlennEVP, Chief Financial Officer69,213Mar 5, 20240
Crowley John FDirector11,716Jun 16, 20230
Formela Jean FrancoisDirector7,291Jun 16, 20220
Dorsa CarolineDirector12,701Jun 16, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 6, 2021 (view filing)Aug 51 dayGoddard GlennEVP, Chief Financial OfficerSSale−20.0K$151.05−$3.02M−100.0%0 after3 lots
Aug 6, 2021 (view filing)Aug 42 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−26.0K$138.24−$3.59M−91.6%2.39K after7 lots
Aug 11, 2021 (view filing)Aug 92 daysLebwohl DavidEVP, Chief Medical OfficerSSale−2.40K$164.05−$393.7K−75.2%791 after
Aug 20, 2021 (view filing)Aug 191 dayLeonard John MPresident and CEOSSale−22.7K$151.28−$3.43M−3.1%719.3K after3 lots
Aug 25, 2021 (view filing)Aug 232 daysLeonard John MPresident and CEOSSale−27.1K$152.01−$4.13M−3.6%719.3K after3 lots
Sep 1, 2021 (view filing)Aug 30-312 daysGoddard GlennEVP, Chief Financial OfficerSSale−30.0K$159.45−$4.78M−100.0%0 after9 lots
Sep 1, 2021 (view filing)Aug 302 daysLebwohl DavidEVP, Chief Medical OfficerSSale−2.40K$158.04−$379.3K−75.2%791 after5 lots
Sep 1, 2021 (view filing)Aug 302 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−97.0K$154.83−$15.0M−97.6%2.39K after9 lots
Sep 1, 2021 (view filing)Aug 30-Sep 12 daysLeonard John MPresident and CEOSSale−121.4K$160.83−$19.5M−14.4%719.3K after11 lots
Sep 9, 2021 (view filing)Sep 72 daysGoddard GlennEVP, Chief Financial OfficerSSale−3.48K$180.12−$627.2K−100.0%0 after
Sep 23, 2021 (view filing)Sep 212 daysLebwohl DavidEVP, Chief Medical OfficerSSale−2.40K$149.81−$359.5K−75.2%791 after
Oct 7, 2021 (view filing)Oct 52 daysCrowley John FDirectorSSale−10.0K$130.54−$1.31M−82.7%2.09K after5 lots
Oct 13, 2021 (view filing)Oct 112 daysCrowley John FDirectorSSale−2.50K$119.55−$298.9K−54.4%2.09K after
Oct 15, 2021 (view filing)Oct 141 dayLebwohl DavidEVP, Chief Medical OfficerSSale−2.40K$128.44−$308.2K−21.6%8.71K after5 lots
Nov 9, 2021 (view filing)Nov 54 daysLebwohl DavidEVP, Chief Medical OfficerSSale−2.40K$132.72−$318.5K−21.6%8.71K after4 lots
Mar 3, 2022 (view filing)Jan 161 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−1.15K$112.25−$128.9K−19.3%4.82K afterFrom original
Mar 3, 2022 (view filing)Jan 161 daysLebwohl DavidEVP, Chief Medical OfficerSSale−1.05K$112.24−$118.0K−8.8%10.9K afterFrom original
Mar 3, 2022 (view filing)Jan 161 daysGoddard GlennEVP, Chief Financial OfficerSSale−1.01K$112.24−$113.7K−33.1%2.05K afterFrom original
Mar 4, 2022 (view filing)Jan 162 daysLateLeonard John MPresident and CEOSSale−2.49K$112.26−$279.9K−0.3%724.7K after
Jan 6, 2023 (view filing)Jan 42 daysBasta JamesEVP, General CounselSSale−1.14K$37.21−$42.3K−5.5%19.6K after
Jan 6, 2023 (view filing)Jul 1, 2022-Jan 4, 2023189 daysLateClark ElianaEVP, Chief Technical OfficerSSale−2.03K$37.65−$76.4K−12.3%14.5K after3 lots
Jan 6, 2023 (view filing)Jan 42 daysGoddard GlennEVP, Chief Financial OfficerSSale−2.43K$37.21−$90.3K−13.6%15.4K after
Jan 6, 2023 (view filing)Jan 42 daysLebwohl DavidEVP, Chief Medical OfficerSSale−2.57K$37.21−$95.8K−9.1%25.7K after
Jan 6, 2023 (view filing)Jan 42 daysHicks DerekEVP, Chief Business OfficerSSale−1.81K$37.21−$67.4K−9.5%17.3K after
Jan 6, 2023 (view filing)Jan 42 daysLeonard John MPresident and CEOSSale−6.67K$37.21−$248.3K−0.9%766.8K after
Jan 6, 2023 (view filing)Jan 4-52 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−4.84K$37.82−$183.0K−21.5%17.6K after3 lots
Mar 3, 2023 (view filing)Mar 21 dayBasta JamesEVP, General CounselSSale−1.09K$43.88−$47.7K−1.9%55.3K after
Jun 22, 2023 (view filing)Jun 202 daysClark ElianaEVP, Chief Technical OfficerSSale−5.00K$45.00−$225.0K−10.0%45.1K after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysClark ElianaEVP, Chief Technical OfficerSSale−360$40.51−$14.6K−0.8%45.1K after
Jul 10, 2023 (view filing)Jul 64 daysBhanji MunaDirectorSSale−1.87K$39.30−$73.4K−13.0%12.5K after10b5-1
Aug 2, 2023 (view filing)Jul 312 daysBhanji MunaDirectorSSale−265$42.33−$11.2K−2.1%12.3K after10b5-1
Nov 2, 2023 (view filing)Oct 312 daysBhanji MunaDirectorSSale−265$23.90−$6.33K−2.2%12.0K after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysClark ElianaEVP, Chief Technical OfficerSSale−4.61K$29.50−$136.0K−10.1%40.8K after2 lots
Jan 5, 2024 (view filing)Jan 32 daysBasta JamesEVP, General CounselSSale−3.81K$29.46−$112.1K−6.9%51.5K after
Jan 5, 2024 (view filing)Jan 32 daysHicks DerekEVP, Chief Business OfficerSSale−3.88K$29.46−$114.2K−9.5%37.0K after
Jan 5, 2024 (view filing)Jan 32 daysGoddard GlennEVP, Chief Financial OfficerSSale−5.37K$29.46−$158.1K−11.7%40.6K after
Jan 5, 2024 (view filing)Jan 32 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−5.53K$29.46−$163.0K−10.7%46.2K after
Jan 5, 2024 (view filing)Jan 32 daysLebwohl DavidEVP, Chief Medical OfficerSSale−5.84K$29.46−$172.1K−9.7%54.4K after
Jan 5, 2024 (view filing)Jan 32 daysLeonard John MPresident and CEOSSale−19.2K$29.46−$566.3K−2.2%846.5K after
Jan 10, 2024 (view filing)Jan 82 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−2.27K$28.87−$65.7K−4.9%43.9K after2 lots10b5-1
Mar 5, 2024 (view filing)Mar 41 dayClark ElianaEVP, Chief Technical OfficerSSale−605$32.99−$20.0K−0.8%71.5K after
Mar 5, 2024 (view filing)Mar 41 dayBasta JamesEVP, General CounselSSale−2.30K$32.99−$75.8K−2.7%81.6K after
Jun 20, 2024 (view filing)Jun 173 daysVerwiel FrankDirectorSSale−1.50K$25.00−$37.6K−7.7%17.9K after10b5-1
Jul 3, 2024 (view filing)Jul 12 daysClark ElianaEVP, Chief Technical OfficerSSale−405$22.93−$9.29K−0.6%71.5K after
Oct 4, 2024 (view filing)Oct 22 daysDube Michael PVP, Chief Accounting OfficerSSale−2.01K$19.01−$38.2K−4.1%47.0K after
Jan 6, 2025 (view filing)Jan 2-34 daysClark ElianaEVP, Chief Technical OfficerSSale−7.98K$12.17−$97.1K−11.1%64.0K after2 lots
Jan 7, 2025 (view filing)Jan 34 daysSepp-Lorenzino LauraEVP, Chief Scientific OfficerSSale−8.97K$12.18−$109.2K−10.4%77.4K after
Jan 7, 2025 (view filing)Jan 34 daysLeonard John MPresident and CEOSSale−26.8K$12.18−$326.5K−2.8%941.1K after
Jan 7, 2025 (view filing)Jan 34 daysHicks DerekEVP, Chief Business OfficerSSale−6.50K$12.18−$79.2K−9.8%59.9K after
Jan 7, 2025 (view filing)Jan 34 daysLebwohl DavidEVP, Chief Medical OfficerSSale−9.56K$12.18−$116.4K−9.8%87.7K after